Symbotic director Charles Kane plans $252K share sale

Two prior sales attributed to Charles F. Kane are identified as 10b5-1 sales, with reported amounts of 2,000 shares each.

Rhea-AI Filing Summary

Symbotic Inc. director Charles Kane reported an intended sale of 6,000 common shares, with an aggregate market value of $252,420.00 and an approximate sale date of October 1, 2026. Morgan Stanley Smith Barney LLC is listed as broker, and NASDAQ is identified as the exchange. The notice lists 129,873,381 shares outstanding.

The 6,000 shares are listed as acquired on June 7, 2022, through a private acquisition from the issuer or an affiliate. The notice also lists two prior 10b5-1 sales for Charles F. Kane: 2,000 shares for $86,420 on August 3, 2026, and 2,000 shares for $78,000 on September 1, 2026.

Key Figures

Shares reported for sale: 6,000 shares Aggregate market value: $252,420.00 Shares outstanding: 129,873,381 shares +4 more

7 metrics

Shares reported for sale 6,000 shares Common shares; approximate sale date October 1, 2026

Aggregate market value $252,420.00 Shares reported for sale

Shares outstanding 129,873,381 shares Common shares

Shares sold 2,000 shares August 3, 2026

Reported sale amount $86,420 August 3, 2026; 2,000 shares

Shares sold 2,000 shares September 1, 2026

Reported sale amount $78,000 September 1, 2026; 2,000 shares

Key Terms

Rule 144, 10b5-1 Sales, Private Acquisition from Issuer or an Affiliate

3 terms

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 Sales regulatory

"10b5-1 Sales for CHARLES F KANE"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Private Acquisition from Issuer or an Affiliate regulatory

"Private Acquisition from Issuer or an Affiliate"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SYM shares did Charles Kane report for sale?

Charles Kane reported 6,000 common shares for sale, with an aggregate market value of $252,420.00 and an approximate sale date of October 1, 2026. Morgan Stanley Smith Barney LLC is listed as broker, and NASDAQ is identified as the exchange.

What recent SYM share sales did Charles Kane report?

The notice lists two prior 10b5-1 sales for Charles F. Kane: 2,000 shares for $86,420 on August 3, 2026, and 2,000 shares for $78,000 on September 1, 2026.

How did Charles Kane acquire the SYM shares reported for sale?

The 6,000 shares were listed as acquired on June 7, 2022, through a private acquisition from the issuer or an affiliate.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 04:32 PM Accepted by SEC EDGAR 10/01/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001203561
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SYMBOTIC INC.
SEC File Number	001-40175
Address of Issuer	200 Research Drive WILMINGTON MASSACHUSETTS 01887
Phone	9782842800
Name of Person for Whose Account the Securities are To Be Sold	CHARLES KANE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6000	252420.00	129873381	10/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/07/2022	Private Acquisition from Issuer or an Affiliate	Issuer			6000	06/07/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHARLES F KANE 200 Research Drive WILMINGTON MA 01887	Common	09/01/2026	2000	78000.00
10b5-1 Sales for CHARLES F KANE 200 Research Drive WILMINGTON MA 01887	Common	08/03/2026	2000	86420.00

144: Remarks and Signature

Remarks
Date of Notice	10/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Charles Kane
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)